216 related articles for article (PubMed ID: 32088725)
1. High Expression of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Esophageal Squamous Cell Carcinoma and its Clinical Prognostic Significance.
He H; Li PC; Jia W; Hu B; Ji CS
Med Sci Monit; 2020 Feb; 26():e920259. PubMed ID: 32088725
[TBL] [Abstract][Full Text] [Related]
2. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC.
Geng QQ; Wu QF; Zhang Y; Zhang GJ; Fu JK; Chen NZ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9473-9479. PubMed ID: 33015789
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.
Yan Y; Zhang D; Lei T; Zhao C; Han J; Cui J; Wang Y
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):928-936. PubMed ID: 31209892
[TBL] [Abstract][Full Text] [Related]
6. p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage.
Li G; Wu J; Li L; Jiang P
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244426
[TBL] [Abstract][Full Text] [Related]
7. Expression and Association of Tumor Necrosis Factor Receptor Associated Factor 4 (TRAF4) in Esophageal Squamous Cell Carcinoma.
Li PC; Hu DD; Jia W; Hu B
Med Sci Monit; 2019 Apr; 25():2368-2376. PubMed ID: 30933965
[TBL] [Abstract][Full Text] [Related]
8. TGFBR3 is an independent unfavourable prognostic marker in oesophageal squamous cell cancer and is positively correlated with Ki-67.
Zhang X; Chen Y; Li Z; Han X; Liang Y
Int J Exp Pathol; 2020 Dec; 101(6):223-229. PubMed ID: 33146446
[TBL] [Abstract][Full Text] [Related]
9. The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.
Yang YS; Yuan Y; Hu WP; Shang QX; Chen LQ
Scand J Gastroenterol; 2018 May; 53(5):533-540. PubMed ID: 29171320
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
11. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
[TBL] [Abstract][Full Text] [Related]
12. miR-92a Inhibits Proliferation and Induces Apoptosis by Regulating Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) Expression in Acute Myeloid Leukemia.
Gu Y; Si J; Xiao X; Tian Y; Yang S
Oncol Res; 2017 Aug; 25(7):1069-1079. PubMed ID: 28059050
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.
Yu C; Yang L; Cai M; Zhou F; Xiao S; Li Y; Wan T; Cheng D; Wang L; Zhao C; Huang X
J Cell Mol Med; 2020 Jan; 24(2):1568-1577. PubMed ID: 31778025
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications.
Ju HQ; Lu YX; Chen DL; Zuo ZX; Liu ZX; Wu QN; Mo HY; Wang ZX; Wang DS; Pu HY; Zeng ZL; Li B; Xie D; Huang P; Hung MC; Chiao PJ; Xu RH
J Natl Cancer Inst; 2019 Jun; 111(6):584-596. PubMed ID: 30534944
[TBL] [Abstract][Full Text] [Related]
16. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
[TBL] [Abstract][Full Text] [Related]
17. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
18. Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Wang J; Luo J; Sun Z; Sun F; Kong Z; Yu J
Medicine (Baltimore); 2020 Sep; 99(37):e22194. PubMed ID: 32925794
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma.
Liu L; Lu Z; Hu X; Su T; Su L; Pu H
Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541
[TBL] [Abstract][Full Text] [Related]
20. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
